Tanuk Pharma (India) Limited

Tanuk Pharma (India) Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1995PLC065899 Incorporated 28 February 1995 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma
Revenue · FY 2023
₹235
▲ 5% YoY
Authorised capital
₹8.5 Cr
Registered with MCA
Paid-up capital
₹3.67 Cr
Issued & subscribed
Open charges
₹1.05 Cr
Satisfied ₹6 Cr
Company age
31 yrs
Est. 1995
Directors on board
3
As per MCA filings
GST registrations
1
None active
Last financials
Mar 2023
Balance sheet date

About Tanuk Pharma (India) Limited

Data last updated:

Tanuk Pharma (India) Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 February 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC065899. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹8.5 Cr and a paid-up capital of ₹3.67 Cr. It is led by directors including Pankaj Kumar Thakur and Kidar Nath Bhalla.

Its last annual general meeting (AGM) was held on 25 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at A – 11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, India – 110048.

As per MCA filings, the company has open charges of ₹1.05 Cr and satisfied charges of ₹6 Cr on record. Court records list 13 cases involving the company, including 7 filed by the company and 6 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tanukpharma.com.

Company details

CIN U74899DL1995PLC065899
Registration Number 065899
Incorporation Date 28 February 1995
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Tanuk Pharma (India) Limited's registered office is in New Delhi, Delhi. Its website is tanukpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    A – 11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, India – 110048
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Tanuk Pharma (India) Limited, buy the company report.

Comprehensive company report
Tanuk Pharma (India) Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Tanuk Pharma (India) Limited

FY 2023 filings available

Tanuk Pharma (India) Limited reported revenue of ₹235 (up 5% YoY) for FY 2023.

Revenue · FY 2023
₹235 ▲ 5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▼ 81%
5 years · compounded
▼ 83%

Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 83%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹235
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Tanuk Pharma (India) Limited, buy the company report.

Board of directors of Tanuk Pharma (India) Limited

Tanuk Pharma (India) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Lokesh Kumar SaxenaAdditional Director23 Nov 20232 Years 11 MonthsCurrent
Pankaj Kumar ThakurDirector10 Aug 201610 Years 3 MonthsCurrent
Kidar Nath BhallaDirector02 Feb 201511 Years 9 MonthsCurrent

Peer comparison

Tanuk Pharma (India) Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aahaan Commercials Private Limited₹300 (FY 2019)33.0%Mumbai, Maharashtra, India
Chittaranjan Pharma Private Limited₹264 (FY 2024)-100.0%Kolkata, West Bengal, India
Adorica Care Private Limited₹262 (FY 2025)-100.0%Greater Noida, Uttar Pradesh, India
Twin Shore Towers Private Limited₹252 (FY 2025)Chennai, Tamil Nadu, India
Medidaili Technologies Private Limited₹250 (FY 2019)-100.0%Malur, Karnataka, India
Tanuk Pharma (India) Limitedthis company₹235 (FY 2023)5.0%New Delhi, Delhi, India
Boson Remedies Private Limited₹203 (FY 2024)-100.0%Ghaziabad, Uttar Pradesh, India
Walter Bushnell Healthsciences Private Limited₹192 (FY 2024)-100.0%Mohali, Punjab, India
Hospitrade Private Limited₹173 (FY 2023)Ahmedabad, Gujarat, India
Rudra Pharma Distributors Private Limited₹147 (FY 2019)-100.0%Mumbai, Maharashtra, India
Coral Healthcare Online Private Limited₹134 (FY 2025)-100.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Tanuk Pharma (India) Limited, buy the company report.

Auditor

Tanuk Pharma (India) Limited is audited by BHUVI KANT & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
BHUVI KANT & ASSOCIATESFY 2023007798C

Shareholding

The shareholding of Tanuk Pharma (India) Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Tanuk Pharma (India) Limited, buy the company report.

Charges & borrowings

Open charges
₹1.05 Cr
Satisfied charges
₹6 Cr
Breakdown by lending institutions
Housing Development Finance Corporation Limited₹0.70 Cr
Standard Chartered Bank₹0.35 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Mar 201510560192Housing Development Finance Corporation Limited₹70 LakhOpen
19 Sep 201110308925Standard Chartered Bank₹34.5 LakhOpen
16 May 201410500350Bank of Baroda₹3.25 CrSatisfied
10 Feb 199790056668Punjab National Bank₹2.75 CrSatisfied

To see the full charge records of Tanuk Pharma (India) Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Tanuk Pharma (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Tanuk Pharma (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Tanuk Pharma (India) Limited, buy the company report.

Recent activity

Tanuk Pharma (India) Limited has 8 board changes on record since 2015: 3 appointments and 5 cessations. The latest: Anuradha Bhalla ceased to be Director on 28 Nov 2023.

Ceased
Anuradha Bhalla ceased to be Director.
Ceased
Tarun Bhalla ceased to be Director.
Appointed
Lokesh Kumar Saxena was appointed as Additional Director.
AGM
Tanuk Pharma (India) Limited last Annual general meeting of members was held on 25 Sep 2023 as per latest MCA records.
Filing
Tanuk Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Ceased
Pankaj Kumar Thakur ceased to be Additional Director.
Appointed
Pankaj Kumar Thakur was appointed as Director.
Charges
A charge registered on 16 May 2014 via Charge ID 10500350 with Bank Of Baroda was fully satisfied on 22 Jan 2016.
Ceased
Kidar Nath Bhalla ceased to be Additional Director.
Charges
A charge with Housing Development Finance Corporation Limited amounted to Rs. 0.70 Cr with Charge ID 10560192 was registered on 31 Mar 2015.
Appointed
Kidar Nath Bhalla was appointed as Director.
Ceased
Pankaj Kumar Jha ceased to be Director.

6 earlier events are in the company report.

Frequently asked questions

Tanuk Pharma (India) is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 February 1995 (31+ years old) and is registered under CIN U74899DL1995PLC065899.

Tanuk Pharma (India) has 3 current directors:

The latest financial statements of Tanuk Pharma (India) on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 25 September 2023. Year-wise statements from 2015 are in the company report.

No. Tanuk Pharma (India) has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Tanuk Pharma (India) is U74899DL1995PLC065899. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tanuk Pharma (India) has 13 court cases on record: 7 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.

Tanuk Pharma (India) was incorporated on 28 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Tanuk Pharma (India) by revenue are Aahaan Commercials Private Limited, Chittaranjan Pharma Private Limited, Adorica Care Private Limited, Twin Shore Towers Private Limited, Medidaili Technologies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Anuradha Bhalla ceased to be Director on 28 Nov 2023. Tarun Bhalla ceased to be Director on 28 Nov 2023. Lokesh Kumar Saxena was appointed as Additional Director on 23 Nov 2023. Tanuk Pharma (India) has 8 board changes on record in total.

Tanuk Pharma (India) can be reached through the website tanukpharma.com. Its registered office is in New Delhi, Delhi, India.

The registered office of Tanuk Pharma (India) is at A – 11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, India – 110048.